Trade Moderna Inc ^MRNA

Moderna (NASDAQ:MRNA) Earns "Sector Perform" Rating from Royal Bank of Canada

Rhumbline Advisers Sells 20,902 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna (NASDAQ:MRNA) Price Target Lowered to $78.00 at UBS Group

Moderna (MRNA) Expected to Announce Earnings on Thursday

Moderna (NASDAQ:MRNA) Stock Price Up 8.8% - Time to Buy?

Moderna's (MRNA) "Sector Perform" Rating Reiterated at Royal Bank of Canada

Moderna: A Generational Opportunity for Investors in 2025 | Investing.com

Why Moderna (MRNA) Went Up on Tuesday?

MRNA: A Once-in-a-Generation Opportunity for Investors in 2025

Moderna (NASDAQ:MRNA) Stock Rating Lowered by Barclays

Moderna price target lowered to $78 from $96 at UBS | Markets Insider

Top Defense Stocks To Research - February 18th

Stock Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA)

Moderna Downgraded by Barclays as Policy Risks and Weak Revenue Weigh on Outlook

Early notable gainers among liquid option names on February 18th

Morgan Stanley Keeps Their Hold Rating on Moderna (MRNA) | Markets Insider

Moderna downgraded to Equal Weight from Overweight at Barclays | Markets Insider

RBC Capital Sticks to Its Hold Rating for Moderna (MRNA) | Markets Insider

'Medical coercion': U.S. Dept. of Veterans Affairs still insists on COVID vax mandate

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release? - February 18, 2025 - Zacks.com

Moderna price target raised to $39 from $38 at Morgan Stanley | Markets Insider

Bernstein Reaffirms Their Hold Rating on Moderna (MRNA) | Markets Insider

Moderna, Inc. (NASDAQ:MRNA) Q4 2024 Earnings Call Transcript

Baillie Gifford & Co. Has $1.62 Billion Stake in Moderna, Inc. (NASDAQ:MRNA)

Intrinsic Value Partners LLC Decreases Holdings in Moderna, Inc. (NASDAQ:MRNA)

AustralianSuper Pty Ltd Purchases 2,077 Shares of Moderna, Inc. (NASDAQ:MRNA)

Best Pharmaceutical Stocks To Watch Now - February 14th

Moderna (NASDAQ:MRNA) Shares Gap Down - What's Next?

Banque Pictet & Cie SA Sells 22,425 Shares of Moderna, Inc. (NASDAQ:MRNA)

Vontobel Holding Ltd. Has $10.74 Million Holdings in Moderna, Inc. (NASDAQ:MRNA)

Compagnie Lombard Odier SCmA Sells 8,018 Shares of Moderna, Inc. (NASDAQ:MRNA)

Rep. Julie Johnson Unloads Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ:MRNA) Shares Purchased by Vontobel Holding Ltd.

Moderna Inc (MRNA) Q4 2024 Earnings Call Highlights: Navigating Challenges and Strategic Shifts

Q4 2024 Moderna Inc Earnings Call Transcript

Health Care Down as Moderna Shares Slide - Health Care Roundup | Morningstar

Moderna price target lowered to $25 from $35 at Wolfe Research | Markets Insider

Moderna says norovirus vaccine trial on FDA clinical hold | Markets Insider

Best Biotech Stocks To Keep An Eye On - February 14th

Moderna Earnings: Maintaining Our $102 Fair Value Estimate as Long-Term Pipeline and Strategy Intact | Morningstar

Moderna's Shot Sales, Canceled Contract Lead to Another Loss

Moderna trading resumes | Markets Insider

Moderna trading halted, volatility trading pause | Markets Insider

Hedge fund giant Bridgewater made a new bet on Tesla. They may have gotten a bargain. | Morningstar

News Highlights: Top Company News of the Day - Friday at 9 AM ET | Morningstar

Moderna (MRNA) Reports Wider-Than-Expected Losses Amid Decreased Vaccine Demand

Moderna is counting on its product pipeline to resuscitate its ailing stock | Morningstar

News Highlights: Top Company News of the Day - Friday at 7 AM ET | Morningstar

Moderna looks to pipeline to restore battered stock after quarterly loss | Morningstar

Moderna (MRNA) Q4 earnings 2024

Moderna's wider-than-expected loss and soft guidance weigh on battered stock | Morningstar

Moderna posts bigger loss than expected as vaccine maker scales down manufacturing

Moderna beats on revenue but loses more than expected as it scales down manufacturing

Moderna Stock Down 5% As Q4 EPS Misses Estimates, But Revenues Top

Guillain-Barré case puts Moderna norovirus vax trial on hold | BioWorld

Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline - February 14, 2025 - Zacks.com

Senate votes to confirm Robert Kennedy as head of HHS | Markets Insider

Moderna fined for trying to lure children into Covid vaccine trials with teddy bears

Sumitomo Mitsui DS Asset Management Company Ltd Increases Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Moderna (MRNA) Projected to Post Quarterly Earnings on Friday

Bank of America Issues Pessimistic Forecast for Moderna (NASDAQ:MRNA) Stock Price

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Sumitomo Mitsui Trust Group Inc.

Moderna (NASDAQ:MRNA) Hits New 1-Year Low - Here's Why

BioMarin Pharmaceutical (BMRN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - February 12, 2025 - Zacks.com

Bank of America Cuts Moderna (NASDAQ:MRNA) Price Target to $34.00

Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2024 Earnings Call Transcript

Moderna price target lowered to $34 from $41 at BofA

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Mirae Asset Global Investments Co. Ltd.

Insights Into Moderna (MRNA) Q4: Wall Street Projections for Key Metrics - February 11, 2025 - Zacks.com

Biogen Gears Up to Report Q4 Earnings: What's in the Cards? - February 11, 2025 - Zacks.com

Activest Wealth Management Sells 386 Shares of Moderna, Inc. (NASDAQ:MRNA)

Why Moderna Inc. (MRNA) Crashed Last Week

Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast? - February 10, 2025 - Zacks.com

Quattro Financial Advisors LLC Acquires 22,500 Shares of Moderna, Inc. (NASDAQ:MRNA)

Are These 5 Biotech Stocks Set to Beat Q4 Earnings Estimates? - February 3, 2025 - Zacks.com